Rigel Pharmaceuticals (RIGL) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -47.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.51% |
| Dec 31, 2025 | -257.38% |
| Sep 30, 2025 | -131.16% |
| Jun 30, 2025 | -26.72% |
| Mar 31, 2025 | -51.98% |
| Dec 31, 2024 | 140.02% |
| Sep 30, 2024 | 560.24% |
| Jun 30, 2024 | 22.89% |
| Mar 31, 2024 | -145.57% |
| Dec 31, 2023 | -133.55% |
| Sep 30, 2023 | -227.50% |
| Jun 30, 2023 | 238.10% |
| Mar 31, 2023 | 173.38% |
| Dec 31, 2022 | 53.04% |
| Sep 30, 2022 | 104.90% |
| Jun 30, 2022 | -96.11% |
| Mar 31, 2022 | 156.06% |
| Dec 31, 2021 | -85.87% |
| Sep 30, 2021 | -55,630.61% |
| Jun 30, 2021 | 839.79% |
| Mar 31, 2021 | -145.48% |
| Dec 31, 2020 | 62.62% |
| Sep 30, 2020 | 101.91% |
| Jun 30, 2020 | 71.26% |
| Mar 31, 2020 | 1,496.31% |
| Dec 31, 2019 | -211.70% |
| Sep 30, 2019 | -42.98% |
| Jun 30, 2019 | -222.10% |
| Mar 31, 2019 | -188.61% |
| Dec 31, 2018 | 19.54% |
| Sep 30, 2018 | 46.48% |
| Jun 30, 2018 | 430.37% |
| Mar 31, 2018 | -91.85% |
| Dec 31, 2017 | 249.21% |
| Sep 30, 2017 | -768.53% |
| Jun 30, 2017 | -170.74% |
| Mar 31, 2017 | 177.13% |
| Dec 31, 2016 | -270.49% |
| Sep 30, 2016 | -95.28% |
| Jun 30, 2016 | 141.99% |
| Mar 31, 2016 | -206.08% |
| Dec 31, 2015 | 104.23% |
| Sep 30, 2015 | 292.33% |
| Jun 30, 2015 | -383.42% |
| Mar 31, 2015 | 562.90% |
| Dec 31, 2014 | -50.47% |
| Sep 30, 2014 | -89.62% |
| Jun 30, 2014 | 168.42% |
| Mar 31, 2014 | -980.59% |
| Dec 31, 2013 | -27.83% |
| Sep 30, 2013 | -998.00% |
| Jun 30, 2013 | -418.43% |
| Mar 31, 2013 | -80.15% |
| Dec 31, 2012 | 13,738.78% |
| Sep 30, 2012 | 102.68% |
| Jun 30, 2012 | -76.12% |
| Mar 31, 2012 | -79.80% |
| Dec 31, 2011 | 99.63% |
| Sep 30, 2011 | -138.62% |